lactose has been researched along with erythromycin in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (30.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
McKay, LL; Polzin, KM; Steele, JL | 1 |
Krofton, DV | 1 |
Belozerova, OP; Koroleva, VG; Stepnaia, VE; Vasil'ev, VK | 1 |
Delley, M; Knol, J; Marciset, O; Mollet, B; Poolman, B | 1 |
Ida, Y; Kawakami, K; Numa, T | 1 |
Antikainen, O; Jouppila, K; Jørgensen, AC; Karjalainen, M; Miroshnyk, I; Rantanen, J; Siiriä, S | 1 |
Liu, HC; Pei, XF; Wang, C; Yu, Q; Zhang, CW | 1 |
10 other study(ies) available for lactose and erythromycin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Characterization of the genetic element coding for lactose metabolism in Lactococcus lactis subsp. lactis KP3.
Topics: Bacteriophages; Conjugation, Genetic; Deoxyribonuclease EcoRI; Erythromycin; Genes, Bacterial; Lactococcus lactis; Lactose; Lactose Factors; Maltose; Mutation; Nucleic Acid Hybridization; Phenotype; Plasmids; Recombination, Genetic; Rifampin; Streptomycin; Transformation, Bacterial | 1989 |
[Chemotherapy of respiratory diseases].
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Bronchiectasis; Bronchitis; Cephaloridine; Chloramphenicol; Chronic Disease; Cloxacillin; Erythromycin; Humans; Lactose; Methicillin; Oxytetracycline; Penicillin G; Penicillin Resistance; Pneumonia; Pneumonia, Staphylococcal; Pneumonia, Viral; Streptomycin; Tetracycline | 1971 |
[Effect of acid protective coating on absorption of erythromycin at oral administration].
Topics: Animals; Cellulose; Dogs; Erythromycin; Gastric Juice; Intestinal Absorption; Lactose; Tablets, Enteric-Coated; Technology, Pharmaceutical | 1969 |
Directed genomic integration, gene replacement, and integrative gene expression in Streptococcus thermophilus.
Topics: Base Sequence; beta-Galactosidase; Biological Transport; Chloramphenicol O-Acetyltransferase; Chromosomes, Bacterial; Drug Resistance, Microbial; Erythromycin; Escherichia coli; Galactose; Genes, Bacterial; Lac Operon; Lactose; Molecular Sequence Data; Oligodeoxyribonucleotides; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Restriction Mapping; Streptococcus; Transformation, Bacterial | 1993 |
Assessment of amorphous content by microcalorimetry.
Topics: Anti-Bacterial Agents; Calorimetry; Crystallization; Erythromycin; Lactose; Powders; Solvents | 2002 |
Multivariate data analysis as a fast tool in evaluation of solid state phenomena.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Crystallization; Crystallography, X-Ray; Desiccation; Erythromycin; Excipients; Lactose; Multivariate Analysis; Nitrofurantoin; Pharmaceutical Preparations; Principal Component Analysis; Spectrum Analysis, Raman; Temperature; Water; Wettability | 2006 |
Non-fusion and fusion expression of beta-galactosidase from Lactobacillus bulgaricus in Lactococcus lactis.
Topics: beta-Galactosidase; Erythromycin; Gene Expression Regulation, Bacterial; Lactobacillus; Lactococcus lactis; Lactose; Recombinant Proteins; Time Factors | 2008 |